THERAVANCE BIOPHARMA INC (TBPH)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for TBPH
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| TBPH | Chief Executive Officer and Director | 66 | ["M.B.A. from Texas Christian University","B.S. degree from Southern Illinois University","Served as Chief Executive Officer since June 2014","Former CEO of Innoviva","Experience in oncology/hematology from Bristol Myers Squibb","Chairman of CHI and CLSA","Member of Biotechnology Industry Organization’s board"] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| JAZZ | Chief Executive Officer, Theravance Biopharma, Inc.; Lead Independent Director; Member | 66 | ["Experience in senior management positions in the pharmaceuticals industry","Significant industry knowledge","Operational and management expertise","Deep knowledge of global marketing, commercialization and market access"] | ["Audit Committee","Compensation Committee","Nominating Committee"] | 2026 |
| INVA | Chief Executive Officer and Director | 54 | [] | [] | 2014 |
Biography sourced from the proxy statement filing.
Rick E Winningham has served on the board of directors since July 2013, including as Chairman until October 2024. He has served as our Chief Executive Officer since our spin-off from Innoviva in June 2014. From October 2001 to August 2014, Mr. Winningham served as Chief Executive Officer of Innoviva, where he also served as Chairman of t